One of the hallmarks of integrin signaling is an increase in cell migration and invasion, both of which are associated with actin filament rearrangements. Integrin-linked kinase (ILK) is a cytoplasmic effector of integrin receptors. ILK is known to be involved in multiple cellular functions. However, the signaling pathways involved in ILKmediated cellular structure and motility remain to be elucidated. Here, we have demonstrated that overexpression of ILK was sufficient to induce actin filament rearrangements, to form cell motility structures, and to increase cell migration and invasion in a phosphatidylinositol 3-kinase (PI3K)-dependent manner. This corresponds with the activation of both Akt and p70 ribosomal protein S6 kinase (p70S6K1). Overexpression of dominantnegative mutants of Akt inhibited ILK-dependent activation of p70S6K1, indicating that Akt is upstream of p70S6K1 in response to ILK signaling. Overexpression of ILK was sufficient to induce Rac1 activation, which was abolish by a PI3K inhibitor, indicating that Rac1 activity is involved in ILK signaling in a PI3K dependent manner. Inhibition of Akt, Rac1, or p70S6K1 inhibited the effects of ILK on actin filaments and cell migration, suggesting a regulatory role of the PI3K/Akt/p70S6K1/Rac1 signaling pathway in response to ILK signaling. We have shown that overexpression of a dominant-negative ILK was sufficient to abolish fibronectin peptide (PHSRN)-induced rearrangements of actin filaments and cell migration and invasion. Taken together, our results identify a mechanism through which ILK can regulate both integrin-associated rearrangements of actin filaments and cell migration and invasion at the integrin receptor-proximal region.
Introduction
Integrin-linked kinase (ILK) is a binding partner of the integrin b1 and b3 subunits and is involved in the signal transduction from integrin receptors (Hannigan et al., 1996; Wu and Dedhar, 2001) . ILK is involved in cell survival, cell cycle progression, cell adhesion, cell spreading, and extracellular matrix (ECM) modification (Wu and Dedhar, 2001 ). Moreover, it was found to anchor actin filaments to cell matrix contact sites, and to be associated with actin filaments through multiple protein interactions, including PINCH, CH-ILKBPactopaxin-a-parvin, paxillin, affixin-b-parvin, and integrin (Wu, 1999; Wu and Dedhar, 2001) . ILK was also found to be involved in the regulation of changes in cell shape and cell migration through a PINCH-ILK interaction .
Dynamic changes in actin filaments are involved in a wide variety of cellular processes including cell motility, cell cycle control, cellular structure, and cell signaling (Schmidt and Hall, 1998) . The rearranged actin filaments form discrete structures at the cell periphery that mediate attachment to the substratum, which is regulated by both extracellular and intracellular signals (Hall, 1998; Svoboda et al., 1999) . Those discrete structures are stress fibers, lamellipodia, filopodia, and membrane ruffles, all of which are essential for cell migration and invasion (Hall, 1998) .
It has been found that integrins induce rearrangements of actin filaments and increase cell migration and invasion through multiple intracellular signaling pathways (Defilippi et al., 1999; Calderwood et al., 2000; Mercurio and Rabinovitz, 2001) . However, the molecular events at the integrin receptor-proximal region that trigger the intracellular signals have not fully been identified (Schwartz, 2001) . The integrin-associated protein FAK was demonstrated to mediate integrininduced actin filament rearrangements (Parsons et al., 2000; Gerthoffer and Gunst, 2001) ; however, overexpression of FAK in chicken fibroblast cells (CEF) was unable to induce actin filament rearrangements (MD Schaller, personal communication) . This indicates that FAK is not an immediate downstream kinase for integrin control of actin filament integrity. ILK anchors actin filaments to integrins and the cell membrane (Hannigan et al., 1996; Zervas et al., 2001) , indicating that ILK may be involved in the rearrangement of actin filaments and the formation of cell motility structures at the leading edge of the cell membrane. Previous studies have demonstrated that deletion mutations of ILK induce the detachment of actin filaments from the cell membranes at the muscle's attachment sites in a similar manner as the phenotype of integrin deletion (Zervas et al., 2001) . Little is known about the molecular mechanisms and signaling pathways involved in ILKmediated cellular structure and motility. In this study, we want to determine:
(1) whether expression of ILK alone has the ability to induce rearrangements of actin filaments that lead to the increase in cell migration and invasion; (2) whether phosphatidylinositol 3-kinase (PI3K) signaling is involved in ILK-mediated actin filament rearrangements and migration and invasion; and (3) the identity of the downstream molecules that regulate these ILK-induced cellular functions.
We demonstrated that overexpression of ILK was sufficient to induce rearrangements of actin filaments and increases in cell migration and invasion. We found that overexpression of ILK was sufficient to activate both Akt and p70 ribosomal protein S6 kinase (p70S6K1) in a PI3K-dependent manner, and that p70S6K1 was a downstream protein of Akt in ILK signaling. Inhibition of PI3K, Akt, or p70S6K1 eliminated ILK-induced rearrangements of actin filaments and inhibited cell migration and invasion. We also demonstrated that overexpression of a dominant-negative ILK was sufficient to disrupt a fibronectin peptide (PHSRN)-induced actin filament rearrangements, cell migration, and invasion. Furthermore, we demonstrated that overexpression of ILK induced the activation of Rac1 and that overexpression of a dominant-negative Rac1 was sufficient to abrogate ILK-induced actin filament rearrangements and cell migration. These results identify the molecular events that trigger both morphological and motility changes in integrin signaling at the integrin receptor-proximal region.
Results
Overexpression of ILK is sufficient to induce actin filament rearrangements in a PI3K-dependent manner
To determine if ILK has the ability to induce rearrangements of actin filaments, CEF cells were infected with RCAS-ILK to overexpress ILK. After 9 days of infection, high expression levels of ILK proteins were detected ( Figure 1a ). CEF cells infected with either RCAS alone or RCAS-ILK with a mutation of kinase domain (ILK-KD), a dominant-negative mutant of ILK, were used as controls. Overexpression of ILK induced the distribution of actin filaments onto the cell membrane to form the cell motility structures lamellipodia and filopodia at the leading edge of the cells (Figure 1b ). In contrast, in the cells expressing RCAS alone or RCAS-ILK-KD (Figure 1b) , actin filaments were well organized and distributed evenly throughout the cells and no significant increases in the formation of cell motility structures were detected. These data demonstrated that overexpression of ILK was sufficient to induce rearrangements of actin filaments in CEF cells. To test whether PI3K activity was required for ILKinduced actin filament rearrangements, a PI3K-specific inhibitor, LY294002, was added to the cells expressing ILK. The addition of LY294002 prevented ILK-induced rearrangements of actin filaments in a dose-dependent manner (Figure 1b ), indicating that PI3K signaling was required for ILK-induced actin filament rearrangements.
Overexpression of ILK was sufficient to increase cell migration and invasion in a PI3K-dependent manner
The increased formation of lamellipodia and filopodia indicates that overexpression of ILK in CEF cells may increase cell motility and invasion. It was found previously that overexpression of ILK induced an invasive phenotype in intestinal and mammary epithelial cells (Troussard et al., 2000) . To test this possibility in CEF cells, both cell migration and invasion assays using the transwell chambers were performed in the cells expressing ILK. As shown in Figure 2 , overexpression of ILK in CEF cells increased cell migration and invasion, while overexpression of ILK-KD did not enhance this effect. This indicates that overexpression of ILK was sufficient to increase cell migration and invasion. The results also indicate that ILK-induced morphological changes are consistent with the functional changes (Figure 1b ). To further examine whether the increases in cell migration and invasion required PI3K activity, the cells were preincubated with LY294002 to inhibit PI3K in the cells and then subjected to motility and invasion assays. The preincubation of LY294002 abolished ILK-induced increases in cell migration and invasion in a dose-dependent manner (Figure 2a and b), indicating that activation of PI3K was essential for ILK-induced cell migration and invasion.
Overexpression of ILK is sufficient to activate Akt and p70S6K1 in a PI3K-dependent manner
Akt is a major downstream target of PI3K, and p70S6K1 lies downstream of Akt in response to growth factors. In order to determine whether overexpression of ILK would activate Akt and p70S6K1 in a PI3K-dependent manner, CEF cells overexpressing ILK were treated with the solvent, LY294002, or rapamycin, and were analysed for the phosphorylation of Akt and p70S6K1 by the Western blot. As shown in Figure 3a , overexpression of ILK increased the Akt activation. This activation was inhibited by the addition of LY294002 in a dose-dependent manner (Figure 3a) , indicating that overexpression of ILK is sufficient to activate Akt in a PI3K-dependent manner. Our results are consistent with previous findings in other cell lines, which demonstrated that ILK stimulates activation of Akt (Lynch et al., 1999; Persad et al., 2001; Hill et al., 2002) . Furthermore, overexpression of ILK activated p70S6K1, which required the activation of PI3K signaling. The activation of p70S6K1 was inhibited upon the addition of LY294002 in a dose-dependent manner ( Figure 3b ). Activation of p70S6K1 was also inhibited by rapamycin in a dose-dependent manner ( Figure 3b ). However, mTOR/FRAP inhibitor, rapamycin, had no inhibitory effects on the Akt activation (Figure 3a) , indicating that Akt functions as an upstream signal of p70S6K1 in response to ILK signaling. To further confirm the relationship between Akt and p70S6K1 in response to ILK signaling, the dominant-negative forms of Akt were coexpressed with ILK in CEF cells, and the Western blot analysis was performed in order to examine the activation state of p70S6K1 ( Figure 3c ). The data demonstrated that overexpression of dominant-negative forms of Akt eliminated ILK-induced activation of p70S6K1, confirming that Akt is upstream of p70S6K1 in ILK signaling. Taken together, the results demonstrate that a PI3K-Akt-p70S6K1 pathway is involved in ILK signaling in CEF cells.
Disruption of either Akt or p70S6K1 inhibits ILK's ability both to induce rearrangements of actin filaments and to increase cell migration and invasion
Once we determined that ILK signaling involves a PI3K-Akt-p70S6K1 signaling pathway, we examined whether this signaling pathway regulated ILKinduced rearrangements of actin filaments and increased cell migration and invasion. CEF cells overexpressing ILK were either coexpressed with the dominant-negative Akt constructs (RCAS-B-cellular Akt with a point mutation at the kinase domain (Akt-KD) and RCAS-B-Akt with a mutation of T308A and S473A (Akt-PM)) to inhibit Akt activation or treated with mTOR/FRAP inhibitor, rapamycin, to inhibit p70S6K1 activity. The changes in cell morphology and motility were then examined. The inhibition of Akt and rapamycin treatment abrogated ILK-induced rearrangements of actin filaments and decreased cell migration and invasion . As rapamycin indirectly inhibits the kinase activities of p70S6K1 through inhibition of mTOR/FRAP, we further examined the role of p70S6K1 in ILK-induced cell migration and invasion using p70S6K1-KD, a dominant negative of p70S6K1.
In our previous studies, we showed that p70S6K1-KD inhibited endogenous p70S6K1 activities in CEF cells (Qian et al., 2004) . Here, we show that overexpression of p70S6K1-KD partially inhibited ILK-induced cell migration and invasion (Figure 4e ), indicating that p70S6K1 is involved in ILK-induced cell mobility. However, the inhibitory effect of p70S6K1 is not as strong as those of rapamycin treatment and Akt dominant-negative mutants. These data indicate that a PI3K-Akt-p70S6K1 signaling pathway regulates ILK-induced actin filament rearrangements and cell migration and invasion.
Overexpression of a dominant-negative ILK is sufficient to disrupt fibronectin-induced actin filament rearrangements and cell migration and invasion
Since we showed that ILK has the ability to induce actin filament rearrangements and cell migration and invasion, we explored the biological relevance of these activities in integrin signaling. A dominant-negative ILK mutant, ILK-KD, was applied to examine whether it would disrupt integrin-induced actin filament rearrangements and cell migration and invasion. Both CEF cells and CEF expressing ILK-KD were stimulated with the fibronectin peptide PHSRN. PHSRN was shown to induce invasion and activation of intracellular signaling via binding to a5b1 integrins (Livant et al., 2000; Liu and Kao, 2002) . We first examined whether PHSRN stimulation would activate the endogenous Akt in CEF cells. Our results showed that PHSRN induced the activation of Akt within 30 min after the stimulation and that the activation was much higher at 2 h ( Figure 5a ). Since PHSRN was capable of activating the endogenous Akt in CEF cells, it was applied to CEF cells in order to detect the stimulatory effects on the changes in actin filament integrity and cell migration and invasion. The treatment of PHSRN induced actin filament rearrangements, which were inhibited by ILK-KD (Figure 5b ). We then stimulated CEF cells expressing vector alone or ILK-KD with PHSRN and found that expression of ILK-KD abrogated PHSRN-induced cell migration and invasion ( Figure 5c and d), thus indicating that disruption of ILK activity inhibits integrin-induced actin filament rearrangements and cell migration and invasion. Our control assays show that a scrambled peptide control, PHSCN, has no stimulatory effects on cell migration and invasion in CEF cells, thus indicating the specificity of PHSRN on cell migration and invasion (Figure 5e and f). Our results demonstrate that the linkage of ILK and actin filaments has a functional implication in integrin signaling, and indicate that integrins may reorganize actin filaments and increase cell migration and invasion through ILK within the receptor-proximal area.
To further demonstrate the biological significance of ILK-induced actin filament rearrangements in integrin signaling, we performed the immunofluorescence assays to examine the proteins located near the lamellipodia. Our results showed that integrin b1, cortactin, and vinculin are localized near the lamellipodia, and associated with the ILK-induced actin filament motile structures ( Figure 6 ). The results indicate that overexpression of ILK in CEF cells recruits other actin filament-associated proteins into the ends of ILKinduced actin filaments.
Overexpression of ILK is sufficient to activate Rac1 in a PI3K-dependent manner
The morphological changes in CEF cells overexpressing ILK indicate that the small Rho GTPases Cdc42/Rac might be involved in ILK-induced cell signaling. The GST-PAK-CRIB/GST-WASP-CRIB pull-down assays were applied to examine whether overexpression of ILK was sufficient to induce the activation of Rac1 and Cdc42 in CEF cells. Overexpression of ILK greatly induced the activation of Rac1 in CEF cells, and this activation was abrogated when the PI3K/Akt/p70S6K1 signaling pathway was inhibited (Figure 7a ). This result indicates that ILK induces the activation of Rac1 in a PI3K-dependent manner. In the similar experiment, Cdc42 was not activated by overexpression of ILK nor inhibited by the downregulation of the PI3K/Akt/ p70S6K1 signaling pathway in CEF cells (Figure 7b ). These results showed that ILK specifically regulated Rac1 but not Cdc42 through the activation of PI3K signaling. To examine whether the disruption of Rac1 activities would inhibit ILK-induced cell migration in CEF cells, the wound healing assays were performed. CEF cells overexpressing ILK were either transiently transfected with pGFP vector or a Rac1 dominantnegative mutant, pRK5mycRacN17. After the cells became confluent, a wound was scratched to examine how the transfected cells moved towards the wound. The results showed that many cells expressing pGFP migrated into the wound within 16 h, while the cells transfecting pRK5mycRacN17 were unable to move into the wound (Figure 7c ). There was a fourfold decrease in cell migration in the cells expressing the dominant-negative mutant (Figure 7c ). We also found that expression of dominant-negative Rac1, RacN17 abolished ILK-induced lamellipodia structures, indicating that ILK-induced actin filament rearrangements are Rac1 dependent (data not shown). These results demonstrate that the disruption of Rac1 activities inhibited ILK-induced cell migration. Overall, our results indicate that the activation of Rac1 is essential for ILK-induced actin filament rearrangements and cell migration. The cells were cultured in serum-free medium overnight, followed by incubation in 50 ng/ml of PHSRN, a fibronectin peptide (c and d) or 50 ng/ml of PHSCN, a scrambled peptide control (e and f) for 2 h. The cells were used for the assays of cell migration (c and e) and invasion (d and f) for 16 h as described in Figure 2 
Discussion
Integrins mediate cell migration and invasion through adhesive interactions with the ECM, rearrangements of actin filaments, and the activation of cell signaling pathways in which the rearrangements of actin filaments are critical for cell movement, cell shape maintenance, and the mediation of cell adhesion (Stupack et al., 2000; Mercurio and Rabinovitz, 2001 ). The integrin-induced rearrangements of actin filaments involve the activation of several signaling proteins including Fak, Src, PKC, PI3K, MAP kinase, and small Rho GTPases (Cary et al., 1999; Defilippi et al., 1999; Calderwood et al., 2000; Stupack et al., 2000; Gerthoffer and Gunst, 2001; Schwartz, 2001 ). However, we have yet to understand the molecular events that induce the rearrangements of actin filaments in integrin signaling at the integrin receptor-proximal region.
Our results demonstrate that ILK-induced actin filament rearrangements have a functional role in cell migration and invasion. Upon stimulation, integrins may rearrange actin filaments and increase cell migration and invasion through ILK within the receptorproximal area. Proper regulation of cell migration and invasion is essential for cell development, the generation of new blood vessels, wound healing, and immune response. Therefore, dysregulation of cell migration and invasion is thought to contribute to metastatic cancers and developmental abnormalities (Stupack et al., 2000) . The results obtained from the present study provide evidence of a signaling pathway for the ILK-induced oncogenic transformation of certain cell lines and tumor formation in transgenic mouse models (Dedhar, 2000; White et al., 2001 ). PI3K plays a major role in many cellular activities including cell adhesion, vesicular trafficking, protein synthesis, cell proliferation, and cell survival. PI3K is a key signaling molecule in regulating cell migration and invasion in response to integrin signaling (Shaw et al., 1997; Mercurio and Rabinovitz, 2001 ). As we have confirmed in this paper, the ILK activation regulates cell migration and invasion in a PI3K-dependent manner (Dedhar, 2000) , and ILK induces Akt activation through PI3K. Akt is an essential downstream protein of PI3K (Chan et al., 1999) and is involved in a variety of biological functions including angiogenesis, glycogen synthesis, gene expression, inhibition of apoptosis, cell cycle arrest, endocytosis, vesicular trafficking, and cell transformation (Brazil and Hemmings, 2001 ). The role of actin filament rearrangements in mediating Aktinduced cell migration is controversial. Akt-mediated actin filament rearrangements are essential for endothelial cell migration in response to VEGF signaling, whereas they are not essential for NIH3T3 cell migration in response to PDGF signaling (Morales-Ruiz et al., 2000; Higuchi et al., 2001) . In this study, we found that the activation of Akt was essential for ILK-induced actin filament rearrangements and cell migration and invasion. We believe that the contrary results obtained in response to different stimulators could be due to the activation of different signaling pathways in different cell types. p70S6K1 is one of the major downstream protein kinases of PI3K. Our results have demonstrated that the overexpression of ILK activated p70S6K1, which is downstream of PI3K/Akt. Our results are consistent with the observations in either PI3K-or Aktinduced cell transformation, which demonstrated that the cell transformation was mediated via the phosphorylation and activation of p70S6K1 (Aoki et al., 2001) . Our results are also consistent with the recent observation that p70S6K1 is activated in insulin, PDGF, and EGF signaling (Burgering and Coffer, 1995) . p70S6K1 is localized at the areas of actin stress fibers and actin arc, an actin structure at the leading edge of the cells during cell movement (Berven and Crouch, 2000) . In previous studies, both our group and Blenis' group found that overexpression of a constitutive active form of p70S6K1 is sufficient to induce actin filament rearrangements in different cells (Chou and Blenis, 1996; Qian et al., 2004 ). In the current study, we have proven that ILK-induced actin filament rearrangements and cell migration and invasion are mediated through activation of PI3K, Akt, and p70S6K1. Thus, our results have defined a unique signaling pathway of ILK in regulating the rearrangements of actin filaments and cell motility.
In this study, we also discovered that Rac1 was an essential downstream protein in ILK-induced actin filament rearrangements and cell migration. Rac1 is a key regulator that induces the formation of lamellipodia (Hall, 1998) . It is an important protein in integrin signaling (Van Aelst and D'Souza-Schorey, 1997) . Earlier studies found that high activities of Rac1 coincided with cell adhesion to fibronectin or with the treatment of anti-integrin antibodies (Schwartz and Shattil, 2000) . Recently, it was found that integrins modulated Rac1 activities in a dynamic process that involves PI3K (Schwartz and Shattil, 2000) . Our study provides direct evidence that Rac1 is involved in ILK signaling, and indicates that Rac1 may mediate integrin signaling through the ILK/PI3K pathways.
In conclusion, the results obtained from the present study support the following conclusions:
(1) overexpression of ILK is sufficient to induce rearrangements of actin filaments to form cell motility structures and to increase cell migration and invasion in a PI3K-dependent manner; (2) overexpression of ILK is sufficient to activate both Akt and p70S6K1; (3) overexpression of ILK is sufficient to activate Rac1; (4) a PI3K-Akt-p70S6K1/Rac1 pathway is essential for ILK-induced rearrangements of actin filaments and an increase in cell migration and invasion; and (5) disruption of ILK activity is sufficient to inhibit integrin-mediated rearrangements of actin filaments and an increase in cell migration and invasion.
ILK expression and activity are significantly upregulated in several types of cancers including precancerous colon polyps, colon carcinoma, prostatic adenocarcinoma, and Ewings sarcomas (Wu and Dedhar, 2001; Yoganathan et al., 2002) . Previous research has demonstrated that overexpression and/or constitutive activation of ILK leads to the oncogenic transformation of cell lines and the progression of invasive and metastatic tumors in transgenic mouse models (Persad and Dedhar, 2003) . The results of our study may provide the information necessary to identify new therapeutic targets for cancers and other diseases.
Materials and methods

Materials
Dulbecco's modified Eagle's media (DMEM), TRITC-antirabbit IgG antibody, FITC-anti-mouse IgG antibody, TRITC-phalloidin, and FITC-phalloidin were purchased from Sigma (St Louis, MO, USA). Transwell cell migration chambers were from Corning Costar (Corning, NY, USA). Matrigel-coated invasion chambers were from BD Biosciences (Franklin Lakes, NJ, USA). Antibodies against Akt, phosphoAkt, p70S6K1, and phospho-p70S6K1 were from Cell Signaling (Beverly, MA, USA). Antibody against ILK is from Upstate Biotechnology (Lake Placid, NY, USA). Antibodies against Rac1, Cdc42, cortactin, and integrin b1 were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Antibody against vinculin was purchased from Sigma (St Louis, MO, USA). LY294002 and rapamycin were from Calbiochem (San Diego, CA, USA).
Plasmid constructs and cell preparation
pGST-WASP-CRIB was a gift from Dr Pontous Aspenstrom (Ludwig Institute for Cancer Research, Uppsala, Sweden). The plasmid constructs for ILK, ILK-KD, cellular Akt fused with the amino-terminal sequence of c-Src (Myr-Akt), Akt-KD, and Akt-PM were subcloned into an adaptor vector pBSFI, and then transferred into the RCAS vector, an avian retrovirus vector (Jiang et al., 2000) . CEF cells were prepared from 10-day-old White Leghorn embryos from Spafas (North Franklin, CT, USA) as described previously (Jiang et al., 2000) . CEF cells were transfected with RCAS constructs and cultured to ensure the expression of RCAS retroviral vector carrying the inserts as described (Jiang et al., 2000) .
Immunofluorescence
CEF cells were grown on coverslips. After treatment, the cells were fixed and permeabilized as described previously (Qian et al., 1998) , followed by labeling with FITC-phalloidin and mounting to the slides with Fluoromount (Fisher, Pittsburgh, PA, USA). A Zeiss LSM 510 microscope was used to obtain images. Scale bars were generated and inserted by LSM software.
Western blot
Western blot assays were performed as described previously (Qian et al., 1998) . Briefly, CEF cells were lysed and the cell lysates were subjected to SDS-polyacrylamide gel electrophoresis (SDS-PAGE), followed by transference to a nitrocellulose membrane. The membranes were incubated with specific antibodies and protein bands were visualized with an enhanced chemiluminescence reagent (NEN, Boston, MA, USA).
Cell migration assays
Cell migration assays were conducted as described (Aguiar et al., 2000) with a slight modification. Briefly, the cells were serum-starved overnight and the transwells were coated with ECL cell attachment matrix (Upstate Biotechnology) at 20 mg/ ml. The top chamber of transwell was loaded with 0.2 ml of 4 Â 10 5 cells/ml in serum-free media and the bottom chamber was loaded with 0.6 ml of DMEM medium containing 0.2% FCS. The cells were preincubated with solvent, LY294002, or rapamycin for 2 h, followed by incubation in the transwells at 371C in 5% CO 2 for 16 h. Migrated cells were fixed, stained, and counted using phase-contrast microscopy. Data from replicate experiments were analysed by Microsoft Excel software (Po0.01, n ¼ 3). The images of represented fields were photographed. Some migration assay results were analysed according to methods described previously (Qian et al., 2004) . Briefly, migrating cells were fixed and stained with 0.1% crystal violet, followed by dye elution (10% acetic acid). The microplate reader was used to measure the OD of the eluted solutions to determine the migration values. The mean values were obtained from three individual experiments and were subjected to t-tests.
Wound healing assay
The wound healing assays were performed according to the methods described previously (Qian et al., 2003) . Briefly, CEF cells were grown on coverslips to 100% confluent monolayers and then scratched to form a 100-mm 'wound' using sterile pipette tips. The cells were then cultured in serum-free media for 16 h, fixed on coverslips with formalin, and stained with TRITC-phalloidin for actin and anti-c-myc antibody/FITCanti-mouse IgG antibody for RacN17. A Zeiss LSM 510 microscope was used to obtain images. Scale bars were generated and inserted by LSM software.
Invasion assays
Cell invasion assays were performed according to the manufacturer's protocol (BD Biosciences, Franklin Lakes, NJ, USA). Briefly, the cells were serum-starved overnight and then were loaded on 24-well precoated Matrigel invasion chambers using 0.5 ml of 1 Â 10 5 cells/ml per chamber, and 0.5 ml medium containing 0.2% FCS was added to each well of the BD Falcon TC Companion plates as the chemoattractant. The invasion chambers were incubated in 5% CO 2 at 371C for 16 h. After the incubation, the invaded cells were fixed and stained. Five fields of the invaded cells were counted. The percentage of invaded cells was calculated according to the manufacturer's instructions, and analysed by Microsoft Excel software (Po0.01, n ¼ 3). Some invasion assay results were analysed according to the methods described previously (Qian et al., 2004) . Briefly, migrating cells were fixed and stained with 0.1% crystal violet, followed by dye elution (10% acetic acid). The microplate reader was used to measure the OD of the eluted solutions to determine the migration values. The mean values were obtained from three individual experiments and were subjected to t-tests.
